Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Evoq Remedies Financial Results

Evoq Remedies Limited reported annual revenue of ₹26.76 Crore for FY2026. The board also appointed M/s. Jay Pandya & Associates as secretarial auditors for FY2025-26.

Key figures
Value₹26.76 Cr
Source

BSE filing, BSE: 543500. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Evoq Remedies Ltd: key numbers

Share price
₹1.63
Market cap
₹4.06 Cr
Revenue (annual)
₹25.51 Cr
Net profit (annual)
₹-0.24 Cr
P/E (TTM)
-16.9×Sector 52.3×
Promoter holding
0.02%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Evoq Remedies Ltd

All →

Other financial results announcements

All →
22:26 IST BSE
Financial ResultsSudarshan Pharma Industries Ltd SUDARSHAN

Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY

Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.

Key figure
Net profit ₹8.1 Cr · +92.9% YoY